Mirae Asset Global Investments Co., Ltd. C4 Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$5.3 - $11.0 $219,658 - $455,895	41,445 New	41,445 $338,000
Q1 2023 May 04, 2023	SELL	$3.1 - $9.02 $89 - $261	-29 Reduced 0.17%	17,467 $54,000
Q4 2022 Feb 09, 2023	BUY	$5.42 - $10.24 $97 - $184	18 Added 0.1%	17,496 $103,000
Q3 2022 Nov 10, 2022	SELL	$8.03 - $12.77 $37,267 - $59,265	-4,641 Reduced 20.98%	17,478 $154,000
Q2 2022 Jul 26, 2022	BUY	$5.06 - $26.46 $111,922 - $585,268	22,119 New	22,119 $749,000

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $214M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.